FG
MDXG icon

Formula Growth’s MiMedx Group MDXG Stock Holding History

Formula Growth’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-85,500
Closed -$682K – 161
2016
Q2 		$682K Hold
85,500
– – 0.17% 140
2016
Q1 		$747K Sell
85,500
-7,000
-8% -$58.2K 0.18% 135
2015
Q4 		$867K Buy
+92,500
New +$801K 0.2% 127

Other funds holding MDXG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Formula Growth's MDXG Position: Q3 2016 in Review

Formula Growth sold out of MiMedx Group (MDXG) in Q3 2016, closing a stake of 85,500 shares — an estimated $682K sold.

Formula Growth first reported a position in MDXG in Q4 2015 and held it in 3 quarters. The position peaked at $867K in Q4 2015. 180 funds tracked by Wall St. Rank hold MDXG as of Q3 2016.

  • Formula Growth reported no remaining MiMedx Group position as of Q3 2016 after selling out during the quarter.
  • Formula Growth sold 85,500 MiMedx Group shares in Q3 2016, an estimated $682K.
  • Formula Growth first reported a position in MiMedx Group in Q4 2015 and held it in 3 quarters.
  • Formula Growth's MiMedx Group position peaked at $867K in Q4 2015.
  • 180 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2016.

Based on Formula Growth's 13F filing for Q3 2016, filed 14 Nov 2016.